pipobroman has been researched along with Leukemia L 1210 in 2 studies
Pipobroman: An antineoplastic agent that acts by alkylation.
pipobroman : An N-acylpiperazine that is piperazine in which each of the nitrogens has been acylated by a 3-bromopropionoyl group. An anti-cancer drug.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Graczyk, J | 2 |
| Kowalczyk, K | 1 |
| Pakulska, W | 2 |
| Szadowska, A | 1 |
| Groszkowski, S | 1 |
| Najman, L | 1 |
2 other studies available for pipobroman and Leukemia L 1210
| Article | Year |
|---|---|
[Effect of selected piperazine derivatives on the metabolic clearance rate of idoxuridine-I-125 in mice with transplanted leukemia L1210].
Topics: Animals; Antineoplastic Agents; Female; Idoxuridine; Iodine Radioisotopes; Leukemia L1210; Metabolic | 1981 |
[Antineoplastic activity in mice of 4,4'-(2-methyl-1,4-piperazinodiyl)bis-(4-oxo)-propenyl-1-carboxylic-1 acid diethyl ester].
Topics: Animals; Antineoplastic Agents; Drug Evaluation, Preclinical; Female; Leukemia L1210; Mice; Neoplasm | 1980 |